Skip to main content

Gynecology

Protocols

Ovarian Cancer - Epithelial

Chemotherapy: Platinum-containing regimens

GOCISP

Alternative Treatment of Gynecological Malignancies Using CISplatin and PACLitaxel


GOOVCAD

Primary Treatment with Visible or No Visible Residual Tumour (Moderate, High, or Extreme Risk) or Treatment at Relapse of Invasive Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer, using CARBOplatin and DOCEtaxel


GOOVCADM (replaced by GOOVCAD 01 Sept 2018)

Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer, with No Visible Residual Tumour (Moderate-High Risk) Using CARBOplatin and DOCEtaxel


GOOVCADR (replaced by GOOVCAD 01 Sept 2018)

Second Line Treatment Using DOCEtaxel and CARBOplatin for Epithelial Ovarian Cancer Relapsing after Primary Treatment


GOOVCADX (replaced by GOOVCAD 01 Sept 2018)

Primary Treatment of Visible Residual (Extreme Risk) Invasive Epithelial Ovarian Cancer Using CARBOplatin and DOCEtaxel


GOOVCAG

Treatment of Advanced Ovarian Cancer in Patients Who Have Progressed or Recurred Following First-line Platinum-Based Treatment Using CARBOplatin and Gemcitabine


GOOVCARB

First or Second Line Therapy for Invasive Epithelial Ovarian Cancer Using Single-Agent CARBOplatin


GOOVCATM

Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer, with No Visible Residual Tumour (Moderate-High Risk) Using CARBOplatin and PACLitaxel


GOOVCATR

Second Line Treatment of Invasive Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Relapsing after Primary Treatment Using PACLitaxel and CARBOplatin


GOOVCATX

Primary Treatment of Visible Residual (Extreme Risk) Invasive Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Using CARBOplatin and PACLitaxel


GOOVCIS

Therapy for Invasive Epithelial Ovarian Cancer using CISplatin


GOOVDDCAT

Treatment Of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using CARBOplatin and Weekly PACLitaxel


GOOVFPLDC

First Line Treatment of Epithelial Ovarian Cancer Using DOXOrubicin Pegylated Liposomal (CAELYX) and CARBOplatin


GOOVIPPC

Primary Treatment of Stage III less than or equal to 1 cm Visible Residual Invasive Epithelial Ovarian Cancer or Stage 1 Grade 3 or Stage II Grade 3 Papillary Serous Ovarian Cancer Using Intravenous and Intraperitoneal PACLitaxel and Intraperitoneal CARBOplatin


GOOVPLDC

Treatment of Epithelial Ovarian Cancer Relapsing after Primary Treatment Using DOXOrubicin Pegylated Liposomal (CAELYX) and CARBOplatin


Chemotherapy: Non-platinum-containing regimens

UGOOVBEVG

Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Gemcitabine


UGOOVBEVLD

Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and DOXOrubicin Pegylated Liposomal (CAELYX)


UGOOVBEVP

Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and PACLitaxel


UGOOVBEVV

Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and Vinorelbine


GOOVCYCPO

Palliative Therapy for Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Metronomic Low-Dose Oral Cyclophosphamide 


GOOVDOC

Treatment of Progressive, Platinum-Refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma or Fallopian Tube Carcinoma Using DOCEtaxel


GOOVETO

Treatment of Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Etoposide


GOOVGEM

Treatment of Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Gemcitabine


GOOVLDOX

Treatment of Epithelial Ovarian Cancer Relapsing after Primary Treatment Using DOXOrubicin Pegylated Liposomal (CAELYX)


UGOOVOLAPM

Maintenance Treatment of Relapsed, BRCA-mutated, Platinum Sensitive and Responsive Epithelial Ovarian Cancer Using Olaparib


GOOVTAX3

Treatment of Progressive, Platinum-refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma or Fallopian Tube Carcinoma Using PACLitaxel


GOOVTOP

Treatment of Relapsed/Progressive Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Using Topotecan


GOOVVIN

Palliative Chemotherapy for Re-treatment of Ovarian, Tubal, and Peritoneal Cancer Using Vinorelbine


Hormonal therapy

GOOVAI

Therapy for Advanced Ovarian Cancer Using an Aromatase Inhibitor


GOOVTAM

Therapy for Advanced Ovarian Cancer Using Tamoxifen

Ovarian Cancer - Non-Epithelial

GOBEP

Therapy of Non-Dysgerminomatous Ovarian Germ Cell Cancer Using Bleomycin, Etoposide and CISplatin


GOEP

Therapy of Non-Dysgerminomatous Ovarian Germ Cell Cancer Using Etoposide and CISplatin

Cervical

GOCXAJCAT

Primary Adjuvant Treatment of Adenocarcinoma/Adenosquamous Cancer of the Cervix with CARBOplatin and PACLitaxel Preceding or Following Irradiation with or without CISplatin


GOCXCAD

Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with CARBOplatin and DOCEtaxel in Ambulatory Care Settings


GOCXCAT

Primary Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with CARBOplatin and PACLitaxel in Ambulatory Care Settings


GOCXCATB

Primary Treatment of Metastatic or Recurrent Cancer of the Cervix with Bevacizumab, CARBOplatin and PACLitaxel


GOCXCRT

Treatment of High Risk Squamous Carcinoma, Adenocarcinoma, or Adenosquamous Carcinoma of the Cervix with Concurrent CISplatin and Radiation

Endometrial

Chemotherapy

GOENDCAD

Treatment of Primary Advanced or Recurrent Endometrial Cancer using CARBOplatin and DOCEtaxel


GOENDCAT

Treatment of Primary Advanced or Recurrent Endometrial Cancer using CARBOplatin and PACLitaxel


GOENDD

DOXOrubicin for Use in Patients with Advanced Endometrial Cancer


Hormonal therapy

GOENDAI

Advanced Therapy for Endometrial Cancer using an Aromatase Inhibitor


GOENDH

Non-Aromatase Inhibitor Hormonal Treatment of Endometrial Cancer

Gestational Trophoblastic Neoplasia (GTN)

GOTDEMACO

Therapy for High Risk Gestational Trophoblastic Neoplasia (GTN) Using Etoposide, Methotrexate, Leucovorin (Folinic Acid), DACTINomycin, Cyclophosphamide and vinCRIStine


GOTDLR

Therapy for Low Risk Gestational Trophoblastic Cancer Using DACTINomycin and Methotrexate

Other

GOSAD

DOXOrubicin for Use in Patients with Advanced Uterine Sarcoma

GOSADG

Treatment of Uterine Sarcoma Cancer using DOCEtaxel and Gemcitabine


GOSMCCRT

Treatment of Small Cell or Neuroendocrine Carcinoma of Gynecologic System Origin using PACLitaxel, CISplatin, Etoposide and CARBOplatin with Radiation

Terms of use

The information contained in these documents is a statement of consensus of BC Cancer professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. 

Use of these documents is at your own risk and is subject to BC Cancer's Terms of Use.

Tab Heading
Tab Heading
SOURCE: Gynecology ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2018 Provincial Health Services Authority